Arazlo

Active Ingredient(s): Tazarotene
FDA Approved: * December 18, 2019
Pharm Company: * DOW PHARM
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Arazlo Overview

Tazarotene (marketed as Tazorac, Avage, Zorac, and Fabior) is a third-generation prescription topical retinoid sold as a cream, gel, or foam. Tazarotene is a member of the acetylenic class of retinoids. This medication is approved for treatment of psoriasis, acne, and sun damaged skin (photodamage). It is commonly sold in two concentrations: 0.05% and 0.1%. Contents 1 Mechanism of action 2 Side effects 3 Uses 4 Synthesis 5 Notes Mechanism of action Tazarotene is a retinoid prodrug whi...

Read more Arazlo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tazarotene

Recent Arazlo Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tazarotene

Aerosol, Foam: 0.1%
Cream: 0.05%, 0.1%, 0.10%, 1%
Foam: 0.1%
Gel: 0.05%, 0.1%, 0.10%
Lotion: 0.045%

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Arazlo: (1 result)

Sorted by National Drug Code

0187-2098 Arazlo .45 mg/g Topical Lotion by Bausch Health Us LLC

Other drugs which contain Tazarotene or a similar ingredient: (5 results)

FABIOR Tazarotene
TAZAROTENE
TAZORAC Tazarotene1 discussion
DUOBRII Halobetasol Propionate + Tazarotene
HALOBETASOL PROPIONATE + TAZAROTENE